News

CNBC-TV18, 5 Nov, 21:55

AstraZeneca Pharma Q2 Results: Net profit up 15% on growth across key therapy areas

AstraZeneca Pharma India's Q2 net profit increased 14.9% year-on-year to ₹62.3 crore, while revenue rose 30.4% to ₹729 crore. EBITDA grew 26.7% to ₹95 crore, with the margin at 13.1%. The company also secured…

Read the full story on CNBC-TV18

Headline, summary and picture belong to CNBC-TV18, from its public news feed. We don’t copy the article; the full text is on CNBC-TV18’s site. Prices: Yahoo Finance, delayed.

• Zydus Lifesciences, Granules India offer growth opportunities over next 3-5 years: Shanika Capital

  CNBC-TV18, 9 Nov, 14:21

  Zydus Lifesciences+1.37%
  

• Why Sun Pharma Advanced Research shares surge 11% despite weak sentiments on D-Street; what's boosting medical stock?

  Mint, 9 Nov, 13:10

  

• Gland Pharma shares jump 7% to 52-week high; Nomura sees re-rating but Citi says 'sell'

  CNBC-TV18, 9 Nov, 12:46

  

• Pharma shares shine: Sai, Gland, Divi's, Laurus, Glenmark surge up to 9%

  Business Standard, 9 Nov, 12:23

  

• Up 118% in 6 months! This volume shocker pharma stock skyrockets 14% despite weak trends on Dalal Street Do you own?

  Mint, 9 Nov, 11:34

  

• Gland Pharma shares jump 4% after Q2 profit jumps 58%, revenue rises 23% YoY

  The Economic Times, 9 Nov, 10:56